Patents by Inventor Michiko Harao

Michiko Harao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CDCA1 peptide and pharmaceutical agent comprising the same
    Patent number: 8598125
    Abstract: The present invention provides the peptide of (A) or (B) below, and methods of using the peptide: (A) a peptide including the amino acid sequence of SEQ ID NO: 1 or 2, (B) a peptide which includes the amino acid sequence of SEQ ID NO: 1 or 2, wherein one, two, or several amino acid(s) are substituted, deleted, inserted, and/or added, and wherein the peptide shows killer T cell-inducing activity.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: December 3, 2013
    Assignee: Onco Therapy Science, Inc.
    Inventors: Yasuharu Nishimura, Michiko Harao, Takuya Tsunoda, Yusuke Nakamura
  • IMP-3 OLIGOPEPTIDES AND VACCINES INCLUDING THE SAME
    Publication number: 20120308590
    Abstract: Oligopeptides having cytotoxic T cell inducibility and suitable for use in the context of cancer immunotherapy, more particularly cancer vaccines are described herein. Notable examples include oligopeptides having the amino acid sequence of SEQ ID NO: 1, 3, 5 or 6, wherein 1, 2, or several amino acids are optionally substituted, deleted, inserted or added so long as they retain the cytotoxic T cell inducibility of the original oligopeptides. Pharmaceutical formulations or “drugs” related to such oligopeptides suitable for treating or preventing cancers or tumors, as well as the post-operative recurrence thereof, are also described.
    Type: Application
    Filed: November 30, 2010
    Publication date: December 6, 2012
    Applicant: OncoTherapy Science, Inc.
    Inventors: Yasuharu Nishimura, Michiko Harao, Yusuke Tomita, Yusuke Nakamura, Takuya Tsunoda